[Haplotype of the BRCA2 6857delAA mutation in 4 families with breast/ovarian cancer]
- PMID: 15535929
- DOI: 10.1016/s0025-7753(04)74590-x
[Haplotype of the BRCA2 6857delAA mutation in 4 families with breast/ovarian cancer]
Abstract
Background and objective: It is estimated that 5-10% of all breast cancers are hereditary, mainly are due to germline mutations in the BRCA1 and BRCA2 genes.
Patients and method: A BRCA2 screening was carried out in familial breast/ovarian cancer at two centres in Spain and Chile. The 6857delAA mutation was identified in 3 Spanish families and one Chilean, all of them with Spanish ancestors. The BRCA2 haplotype of the 6857delAA carriers was analyzed using five microsatellite markers flanking the BRCA2 gene, spanning a region of 6 cM: cen-D13S260, D13S1698, (BRCA2), D13S171, D13S310 and D13S267-tel.
Results: Two families shared the allelic variants of the 5 microsatellites studied. Markers D13S260 and D13S267 differed in one allele in two families, respectively. The defined haplotype was absent in non-carriers from these families, and was not detected in 100 control chromosomes without the mutation.
Conclusions: Our results suggest the existence of a common ancestry with the mutation originating in the Northeast of Spain. Given the migratory movements from Spain to Latin America, the screening of recurrent Spanish mutations can be useful in establishing a more rational and cost-effective analysis in such populations.
Similar articles
-
Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families.BMC Med Genet. 2006 Mar 15;7:23. doi: 10.1186/1471-2350-7-23. BMC Med Genet. 2006. PMID: 16539696 Free PMC article.
-
Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.BMC Med Genet. 2016 Feb 6;17:11. doi: 10.1186/s12881-016-0274-6. BMC Med Genet. 2016. PMID: 26852130 Free PMC article.
-
Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain.Hum Mutat. 2003 Apr;21(4):452. doi: 10.1002/humu.9133. Hum Mutat. 2003. PMID: 12655574
-
BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin.Clin Genet. 2010 Jan;77(1):60-9. doi: 10.1111/j.1399-0004.2009.01272.x. Epub 2009 Nov 2. Clin Genet. 2010. PMID: 19912264
-
Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado.Cancer. 2003 Aug 1;98(3):597-602. doi: 10.1002/cncr.11533. Cancer. 2003. PMID: 12879478 Review.
Cited by
-
Prevalence and impact of founder mutations in hereditary breast cancer in Latin America.Genet Mol Biol. 2014 Mar;37(1 Suppl):234-40. doi: 10.1590/s1415-47572014000200009. Genet Mol Biol. 2014. PMID: 24764757 Free PMC article.
-
Non-BRCA1/2 Variants Detected in a High-Risk Chilean Cohort With a History of Breast and/or Ovarian Cancer.J Glob Oncol. 2019 May;5:1-14. doi: 10.1200/JGO.18.00163. J Glob Oncol. 2019. PMID: 31125277 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous